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Abstract
Objective: Gastrointestinal (GI) symptoms appear frequently in patients with
anorexia nervosa (AN), but the associations between psychopathological, GI, and eat-
ing disorder (ED) symptoms remain unclear. This study aimed to determine the rela-
tionships of GI complaints with psychopathological measures, ED symptoms, and
body mass index (BMI) in patients with AN.
Method: Thirty outpatients with AN aged >16 years were included. Psychopathological
measures (Symptom Checklist-90-Revised, Beck Depression Inventory-II, and Beck Anxi-
ety Inventory), ED symptoms (Eating Disorder Examination Questionnaire), ED-
associated impairment (Clinical Impairment Assessment Questionnaire), GI complaints
(Irritable Bowel Syndrome Severity Scoring System [IBS-SSS]), and BMI were assessed
prior to starting treatment, and correlation and multiple regression analyses were applied
to data from 19 patients.
Results: IBS-symptoms were significantly correlated only with ED symptoms
(r = 0.583, p = .009) and somatization (r = 0.666, p = .002). Multiple regression analy-
sis revealed that somatization significantly predicted worse IBS symptoms (beta = 0.5,
p = .04), while ED symptoms did not.
Discussion: Higher IBS-SSS scores were associated with higher severities of other
somatic complaints. GI complaints and somatization should be addressed in treatments
for AN in order to prevent these factors impeding the establishment of healthy eating
patterns.
Clinical trial registration: ClinicalTrials.gov Identifier: NCT02745067.
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1 | INTRODUCTION
Anorexia nervosa (AN) is a debilitating psychiatric disorder with a
high degree of psychiatric comorbidity (Ulfvebrand, Birgegard,
Norring, Hogdahl, & von Hausswolff-Juhlin, 2015). AN is associated
with a wide array of negative health complications, including gas-
trointestinal (GI) symptoms (Mehler & Brown, 2015; Norris et al.,
2016). GI complaints are common in AN, with a reported preva-
lence >95% (Salvioli et al., 2013). Symptoms such as abdominal pain
and discomfort, bloating, abdominal distension, and straining during
bowel movements occur more frequently and are more severe in
patients with AN than in healthy controls (Mack et al., 2016).
Comorbid GI symptoms in AN might represent a preexisting organic
disease, be related to a pathological eating disorder (ED) behavior
(e.g., self-induced vomiting or laxative abuse), represent a conse-
quence of malnutrition and weight loss, be functional in nature, or
represent a combination of all of these possibilities (Boyd, Abra-
ham, & Kellow, 2005; Kress, Paslakis, & Erim, 2018). A recent com-
prehensive literature search of the medical causes of food-related
GI symptoms found that the prevalence of immunological or struc-
tural GI disorders was similar in patients with ED and the general
population. GI complaints are frequent in AN, and most of them are
likely to be functional (Kress et al., 2018). Boyd and colleagues
found that 98% of patients admitted to an ED unit fulfilled the
Rome II criteria for at least one specific functional gastrointestinal
disorder (FGID), predominantly irritable bowel syndrome (IBS)
(Boyd et al., 2005). A more recent study also lists a new FGID, post-
prandial distress syndrome (PDS) as a common disorder in patients
with AN, manifesting as delayed gastric emptying and early satiety
(Wang, Luscombe, Boyd, Kellow, & Abraham, 2014).
Nutritional rehabilitation and weight normalization are key compo-
nents in the treatment of AN. However, the nutritional rehabilitation of
patients with AN is often complicated by comorbid GI symptoms
(Mascolo, Geer, Feuerstein, & Mehler, 2017; Wang et al., 2014).
Addressing the GI complaints in this phase of treatment is challenging
since they might represent a barrier to increasing the food intake. When
rare structural GI disorders are excluded, GI symptoms need to be
addressed cautiously so as to facilitate refeeding of the patient. Except
for Boyd and colleagues' research (Boyd et al., 2005; Wang et al., 2014),
studies assessing the interplay between psychopathological, GI, and ED
symptoms are scarce. A relevant question is whether GI complaints in
AN are mainly associated with the ED pathology and low weight, or also
with another psychopathology such as depression, anxiety, or
somatization.
2 | METHOD
This study formed part of an ongoing longitudinal treatment trial
assessing the efficacy of cognitive behavioral therapy (CBT-E)
(Danielsen, Ardal Rekkedal, Frostad, & Kessler, 2016). The current
study had a cross-sectional design in which patients were assessed
prior to starting treatment. The diagnosis was established by the
treating therapist (psychiatrist/psychologist) based on clinical inter-
view and examination according to DSM 5 criteria. The diagnosis was
further confirmed in an interdisciplinary clinical staff meeting. All
patients were assessed by a medical doctor in order to, among other
things, exclude structural GI disorders.
The study was approved by the Regional Committee for Medical
and Health Research Ethics, Western Norway (REK Vest 2015/2328).
2.1 | Participants
All patients who agreed to receive CBT-E for AN at our outpatient
unit between December 2016 and January 2019 were asked to par-
ticipate in the study. The study included 30 outpatients with AN aged
>16 years. Seven patients did not provide sufficient information about
IBS symptoms, and three patients were excluded due to having a body
mass index (BMI) of >18.5 kg/m2. Data from one patient with a his-
tory of gastric surgery were also excluded, resulting in 19 patients
being eligible for the statistical analyses.
2.2 | Assessment: Self-report questionnaires
2.2.1 | Irritable bowel syndrome severity scoring
system
The Irritable bowel syndrome severity scoring system (IBS-SSS) is a
validated questionnaire for monitoring the severity of IBS symptoms.
It consists of five items related to abdominal pain, abdominal disten-
sion, bowel dysfunction, and quality of life/global well-being scored
on a visual analog scale from 0 to 100 points.
Mild, moderate, and severe cases are indicated by total scores of
75–175, 175–300, and >300, respectively (Francis, Morris, &
Whorwell, 1997).
2.2.2 | Eating disorder examination questionnaire
The eating disorder examination questionnaire (EDE-Q) is a 28-item
instrument measuring eating pathology on a scale from 0 to 6 points
(Fairburn & Beglin, 2008). The present study used the global EDE-Q
score since there is limited evidence for its original four-factor struc-
ture, and several studies have proposed that the global score is an
acceptable indicator of overall eating pathology (Friborg, Reas,
Rosenvinge, & Ro, 2013).
2.2.3 | Clinical impairment assessment
questionnaire
The Clinical impairment assessment (CIA) is a 16-item questionnaire
designed to measure the severity of psychosocial impairment associ-
ated with EDs (Bohn et al., 2008).
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2.2.4 | Symptom Checklist-90-revised
The Symptom Checklist-90-revised (SCL-90-R) is a 90-item question-
naire designed to evaluate a broad range of psychological problems
and symptoms of psychopathology on a scale from 0 to 4 points
(DeRogatis & Unger, 2010). The items are from nine symptom sub-
scales and they include somatization. Somatization was one of the
variables predictive of GI complaints in patients with ED in a previous
study (Boyd et al., 2005), and addressed specifically. The SCL-90-R
somatization subscale comprises 12 questions about somatic com-
plaints. The “nausea or upset stomach” item was omitted to avoid
confounding of the association between GI symptoms and somatiza-
tion, thereby obtaining a subscore for somatization without GI com-
plaints. Furthermore, the Global Severity Index (GSI) was used to
measure the overall psychological distress. To avoid confounding with
the somatization subscale in the correlation analyses, a GSI without
somatization was calculated that consisted of the remaining 78 items.
2.2.5 | Beck depression inventory-II and Beck
anxiety inventory
The Beck depression inventory-II (BDI-II) and Beck anxiety inventory
(BAI) are validated 21-item scales for assessing the severity of
depressive and anxiety symptoms (Beck, Epstein, Brown, & Steer,
1988; Beck, Steer, & Brown, 1996).
2.3 | Statistics
The associations between symptom scores were assessed using bivar-
iate correlation analyses (Pearson correlation coefficient, r). Cohen's
standard was used to evaluate the effect size, with r > 0.5 indicating a
large effect. Multiple regression analysis was used to examine how
much of the variance in IBS symptoms was explained by variables that
were significantly (p ≤ .05) correlated with IBS-SSS scores, and the rel-
ative contributions of these predictors. The predictors were entered
both separately and together in the analyses.
3 | RESULTS
3.1 | Demographic and clinical characteristics
All patients were female, and they were aged 22.3 ± 6.4 years (range
16–38 years) and had a self-reported illness duration of 8.9
± 7.4 years (range 1–14 years) and a BMI of 15.7 ± 1.7 kg/m2 (range
13.2–18.2 kg/m2).
TABLE 1 Severity of IBS symptoms, eating disorder pathology, and psychopathological symptoms in 19 patients with AN prior to starting
treatment, and the associations of IBS symptoms with BMI, eating disorder symptoms, and psychopathological measures
Mean SD Range Percentage of patients with severe symptoms
IBS-SSS scores over the last 10 days
Abdominal pain severity (0–100) 40.8 29.6 0–87 31.6a
Abdominal pain frequency (0–100) 54.7 38.2 0–100 52.6a
Abdominal bloating severity (0–100) 50.6 34.7 0–100 42.1a
Interference with daily activities (0–100) 43.11 33.6 0–100 31.6a
Satisfaction with bowel habits (0–100) 50.8 25.6 2–100 26.3a
Total IBS-SSS score (0–500) 237.3 124.3 50–425 38.8b
Association with IBS-SSS
Pearson correlation coefficient p
EDE-Q global score (0–6) 4.0 1.4 1.7–5.7 0.583 .009
CIA total score (0–48) 36.5 9.0 15–48 0.128 .601
SCL-90-R (0–4)
Somatization without GI complaints 1.8 1.1 0.1–3.6 0.666 .002
Global severity index without somatization 1.6 0.8 0.5–3.5 0.444 .057
BDI-II total score (0–63) 33.5 13.4 15–60 0.267 .268
BAI total scorec (0–63) 20.7 15.5 5–62 0.388 .112
BMI (kg/m2) 15.7 1.7 13.2–18.2 −0.250 .302
Abbreviations: IBS-SSS, Irritable Bowel Syndrome Severity Scoring System; EDE-Q, Eating Disorder Examination Questionnaire; CIA, Clinical Impairment
Assessment Questionnaire; SCL-90-R, Symptom Checklist-90-Revised; GI, gastrointestinal; BDI-II, Beck Depression Inventory-II; BAI, Beck Anxiety
Inventory; SD, standard deviation.
aIBS-SSS item score ≥ 60,
bIBS-SSS score ≥ 300,
cn = 18. The significance level was set to p < 0.05.
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3.2 | Symptom severity
Table 1 lists the severity of IBS symptoms. Three (15.8%), three
(15.8%), six (31.6%), and seven patients (38.8%) reported no, mild,
moderate, and severe IBS symptoms, respectively. Table 1 indicates
that overall the patients had a substantial symptom burden for ED
pathology and psychopathological symptoms.
3.3 | Associations of GI complaints with
psychopathology, ED symptoms, and BMI
Correlation analyses were performed to assess the associations of GI
complaints with psychopathological measures and BMI (Table 1). The
severity of IBS symptoms was significantly correlated (with, according to
Cohen, large effect size) with ED symptoms (EDE-Q) (r = 0.583, p = .009)
and somatization (SCL-90-R somatization subscale without GI com-
plaints) (r = 0.666, p = .002), as shown in Figure 1. GI complaints were
not significantly associated with BMI, global psychopathology (GSI with-
out somatization), psychosocial impairment associated with EDs (CIA), or
depressive or anxiety symptoms (BDI-II and BAI) (Table 1). In simple lin-
ear regression analyses, ED symptoms explained 34% [R2 = 0.34, F
(1,17) = 8.76, p = .009] and somatization explained 44% [R2 = 0.44, F
(1,17) = 13.58, p < .002] of the variance in IBS-SSS scores. Multiple
regression analysis was used to assess the relative contributions of ED
symptoms (EDE-Q total score) and general somatization (SCL-90-R
somatization subscale without GI complaints) to explaining the variance
in IBS symptoms. The two independent variables together explained
49% of the total variance [F(2,16) = 7.7, p < .005]. In this model, somati-
zation significantly predicted IBS symptoms (beta = 0.5, p = .04), while
ED symptoms did not (beta = 0.27, p = .25).
4 | DISCUSSION
This study assessed the associations of IBS symptoms with psycho-
pathological measures, ED symptoms, and BMI in patients with
AN. The severity of GI complaints (IBS-SSS) was strongly correlated with
both somatization and ED pathology (EDE-Q global score), while higher
IBS-SSS scores were associated with greater severities of other somatic
complaints. ED pathology and somatization together explained almost
half of the variance in GI complaints. However, while somatization signif-
icantly predicted the severity of IBS symptoms in the regression analyses,
ED symptoms did not. Furthermore, we found no association between
GI complaints and BMI. The highly prevalent symptoms of anxiety and
depression were not associated with IBS-SSS scores.
Our results are consistent with the findings of (Boyd et al., 2005)
regarding an association between somatization and IBS in patients
with ED (Boyd et al., 2005). Those authors assessed the relationships
between psychological features, ED pathology, and FGID in
101 patients with ED (45 had AN), and found that somatization and
state anxiety were the psychological factors predictive of IBS. In con-
trast, we found no association between anxiety and IBS-SSS scores.
Previous studies involving non-ED populations suffering from IBS
have found a strong symptom overlap with other functional somatic syn-
dromes such as chronic fatigue syndrome, temporomandibular disorder,
and fibromyalgia syndrome (Hausteiner-Wiehle & Henningsen, 2014).
Also, our findings of a strong association between somatization and IBS
symptoms in patients with AN are consistent with the relationships
between anxiety, depression, somatization, and the severity of IBS symp-
toms found in 126 patients with IBS by (Van Oudenhove, Tornblom,
Storsrud, Tack, & Simren, 2016). Those authors found that somatization
levels were associated with more severe GI symptoms, and (as in our
study) this was independent of anxiety but not depression.
Somatization has been defined as the tendency to experience and
communicate psychological distress in the form of somatic symptoms
(Lipowski, 1988). Thus, the high prevalence of GI complaints in
patients with ED could be a manifestation of psychological pathology
via bodily expression (Salvioli et al., 2013). Those authors further dis-
cussed the possibility of a vicious circle whereby hypochondriatic per-
sonality traits perpetuate the experience of GI alterations caused by
malnutrition and maintain ED behaviors (Salvioli et al., 2013).
GI symptoms can delay the recovery from AN due to difficulties
in increasing food intake. Medical conditions causing GI symptoms
during nutritional rehabilitation must be resolved. Our findings sug-
gest that GI complaints could partly be understood as a manifestation
of psychological suffering. However, the healthcare provider must
understand that GI symptoms are distressing regardless of origin. It is
F IGURE 1 Associations of GI
complaints (IBS-SSS) with
(a) eating disorder pathology
[Eating Disorder Examination
Questionnaire (EDE-Q)] and (b)
somatization (Symptom Checklist-
90-Revised [SCL-90-R]
somatization subscale without GI
complaints) in patients with AN
prior to starting treatment
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important to acknowledge the painful nature of nutritional rehabilita-
tion while simultaneously preventing the focus on GI symptoms
becoming an avoidance strategy when addressing the pathology
underlying the ED. Providing psychoeducation about the GI effects of
malnutrition, and about the tendency to focus on bodily symptoms
might facilitate the implementation of problem-solving strategies for
overcoming these barriers to healthy changes in eating patterns, espe-
cially among patients with a somatization tendency.
There were several limitations other than the sample smallness.
We used self-report questionnaires instead of clinical assessments,
which makes it difficult to conclude that all complaints were func-
tional. Our measure for the GI complaints focused on IBS symptoms,
and GI symptoms related to other FGIDs such as PDS were not
assessed. The cross-sectional design of the study made it impossible
to draw conclusions about the causality of the association between GI
complaints and somatization. Furthermore, due to the small sample
size, the multiple regression analysis must be interpreted with caution.
In closing, GI complaints are present in a large subgroup of
patients with AN and are strongly correlated with other somatic com-
plaints. This indicates that both GI complaints and somatization should
be addressed in the treatment of AN in order to prevent these factors
constituting a barrier to the establishment of healthy eating patterns.
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